UltraGreen.ai Limited (SGX:ULG)

Market Cap	2.01B
Revenue (ttm)	177.43M +91.5%
Net Income	97.27M +129.0%
EPS	0.25 -99.7%
Shares Out	1.10B
PE Ratio	10.80
Forward PE	18.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	752,400
Open	1.420
Previous Close	1.430
Day's Range	1.390 - 1.430
52-Week Range	1.180 - 1.860
Beta	n/a
Analysts	Strong Buy
Price Target	1.98 (+39.44%)
Earnings Date	Aug 4, 2026

About UltraGreen.ai

UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related t...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2024
• Employees: 101
• Stock Exchange: Singapore Exchange
• Ticker Symbol: ULG

Financial Performance

In 2025, UltraGreen.ai's revenue was $137.94 million, an increase of 27.70% compared to the previous year's $108.02 million. Earnings were $75.63 million, an increase of 35.15%.

Financial numbers in USD

Analyst Summary

According to 3 analysts, the average rating for ULG stock is "Strong Buy." The 12-month stock price target is $1.98, which is an increase of 39.44% from the latest price.

Price Target

$1.98

(39.44% upside)

Analyst Consensus: Strong Buy